novo nordisk semaglutide products and competitors Nordisk's shortage officially concludes in the US, spelling major threat for weight loss drug compounders Ozempic and Wegovy, Novo Nordisk's

Medicare beneficiaries cannot use the NovoCare savings card (federal anti-kickback rules)

Knudsen, L.B., Lau, J

TrimRx Telehealth Weight Loss Platform Examined in 2026 Consumer Research Report on GLP-1 Medication Access, Pricing Transparency and Safety Considerations An Informational Analysis of TrimRx Compounded Semaglutide and Tirzepatide Programs, Telehealth Prescription Process, Published Pricing Disclosures, Pharmacy Partnerships and Patient Safety Information for 2026 San Diego, California, March 09, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice

However, the dosing may influence how the body responds

Many executives also believe that the FDA's announcement is not the end of the story and expect regulatory and legal action